Related Experiment Videos
Nutrition and malignant disease: implications for surgical practice
S D Heys1, K G Park, P J Garlick
1Department of Surgery, University of Aberdeen, UK.
The British Journal of Surgery
|July 1, 1992
Summary
Nutritional support can reduce complications for malnourished cancer patients undergoing surgery. However, it does not improve survival rates for those receiving chemotherapy or radiation therapy.
Area of Science:
- Oncology
- Nutrition Science
- Immunology
Background:
- Malignant diseases frequently cause weight loss and malnutrition.
- Nutritional support aims to improve patient outcomes by reversing weight loss and reducing morbidity and mortality.
- The role of nutrition in cancer management is a critical area of research.
Purpose of the Study:
- To review the impact of nutritional supplementation on morbidity and mortality in cancer patients undergoing surgery, chemotherapy, or radiotherapy.
- To assess how nutritional support affects host defense mechanisms.
- To examine the influence of nutrients on tumor cell growth.
Main Methods:
- Systematic review of existing literature on nutritional support in cancer patients.
- Evaluation of studies focusing on perioperative, chemotherapy, and radiotherapy contexts.
- Analysis of research on specific nutrients and their effects on cancer.
Main Results:
- Perioperative nutritional support for at least 10 days reduces morbidity and mortality in severely malnourished patients (low serum albumin, significant weight loss).
- Parenteral nutritional support shows no benefit for patients undergoing chemotherapy or radiotherapy regarding tumor response or survival.
- Specific nutrients like arginine, essential fatty acids, and ribonucleotides stimulate anti-tumor defenses and modulate tumor metabolism.
Conclusions:
- Perioperative nutritional support is beneficial for specific malnourished cancer patients.
- Nutritional supplementation does not enhance outcomes for patients on chemotherapy or radiotherapy.
- Targeted nutrients and dietary manipulation present promising avenues for innovative cancer management.